| 000 | 01899 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513233532.0 | ||
| 264 | 0 | _c20010614 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0277-0008 | ||
| 024 | 7 |
_a10.1592/phco.21.3.263.34198 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Z | |
| 245 | 0 | 0 |
_aComparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cMar 2001 |
||
| 300 |
_a263-74 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxazolidinones _xadministration & dosage |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xadministration & dosage |
| 700 | 1 | _aWillke, R J | |
| 700 | 1 | _aPinto, L A | |
| 700 | 1 | _aRittenhouse, B E | |
| 700 | 1 | _aRybak, M J | |
| 700 | 1 | _aPleil, A M | |
| 700 | 1 | _aCrouch, C W | |
| 700 | 1 | _aHafkin, B | |
| 700 | 1 | _aGlick, H A | |
| 773 | 0 |
_tPharmacotherapy _gvol. 21 _gno. 3 _gp. 263-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.21.3.263.34198 _zAvailable from publisher's website |
| 999 |
_c11193010 _d11193010 |
||